Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12531-12543

  Li, Youxing ^a   Zhang, Qi ^a,b   Liu, Yin ^a   Luo, Zhen ^a   Kang, Lei ^a   Qu, Jing ^a   Liu, Weiyong ^a   Xia, Xueshan ^c   Liu, Yingle ^a,b   Wu, Kailang ^a,b   Wu, Jianguo ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Institute of Biotechnology   (China)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE; NONSTRUCTURAL PROTEIN 4B; PROTEIN BCL 2; PROTEIN KINASE C; SERINE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; UPREGULATION; VIRUS PATHOGENESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHINA; DNA PRIMERS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; LUCIFERASES; MATRIX METALLOPROTEINASE 2; MICROSCOPY, FLUORESCENCE; PLASMIDS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84869208713     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01136-12     Document Type: Article

References (70)

1. Ali N, Tardif KD, Siddiqui A. 2002. Cell-free replication of the hepatitis C virus subgenomic replicon. J. Virol. 76:12001-12007.
2. Aligo J, Jia SAZ, Manna D, Konan KV. 2009. Formation and function ofhepatitis C virus replication complexes require residues in the carboxyterminal domain of NS4B protein. Virology 393:68-83.
3. Alter MJ. 1997. Epidemiology of hepatitis C. Hepatology 26:62S- 65S.
4. Bates SH, et al. 2003. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856-859.
5. Bhattacharya S, Ray RM, Johnson LR. 2005. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem. J. 392:335-344.
6. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. 1992. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J. Infect. Dis. 166:1276-1280.
7. Choi HJ, Lee JH, Park SY, Cho JH, Han JS. 2009. STAT3 is involved in phosphatidic acid-induced Bcl-2 expression in HeLa cells. Exp. Mol. Med. 41:94-101.
8. Choo QL, et al. 1989. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359-362.
9. Chung J, Uchida E, Grammer TC, Blenis J. 1997. STAT3 serine phosphorylation by ERK-dependent and-independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17: 6508-6516.
10. Chung YL, Sheu ML, Yen SH. 2003. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int. J. Cancer 107:65-73.
11. Crovatto M, et al. 2000. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 85:356-361.
12. Di Bisceglie AM. 1997. Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S-38S.
13. Egger D, et al. 2002. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76:5974-5984.
14. Einav S, et al. 2008. The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without ha-ras co-transfection. Hepatology 47:827-835.
15. El-Gindy I, El Rahman A, El-Alim MA, Zaki S. 2003. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. Egypt. J. Immunol. 10:27-35.
16. Feng X, et al. 2011. Hepatitis C virus core protein promotes the migration and invasion of hepatocyte via activating transcription of extracellular matrix metalloproteinase inducer. Virus Res. 158:146-153.
17. Ferri C, La Civita L, Zignego AL, Pasero G. 1997. Hepatitis-C-virus infection and cancer. Int. J. Cancer 71:1113-1115.
18. Ferri C, La Civita L, Zignego AL, Pasero G. 1997. Viruses and cancers: possible role of hepatitis C virus. Eur. J. Clin. Invest. 27:711-718.
19. Ferri C, et al. 1995. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas. Clin. Exp. Rheumatol. 13(Suppl. 13):S135-S140.
20. Giraud S, et al. 2002. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J. Biol. Chem. 277:8004-8011.
21. kB. Proc. Natl. Acad. Sci. U. S. A. 98:9599-9604.
22. Gosert R, et al. 2003. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J. Virol. 77:5487-5492.
23. Guo XZ, Shao XD, Liu MP. 2002. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J. Gastroenterol. 8:1059-1062.
24. Hellings JA, van der Veen-du Prie J, Snelting-van Densen R, Stute R. 1985. Preliminary results of transmission experiments of non-A, non-B hepatitis by mononuclear leucocytes from a chronic patient. J. Virol. Methods 10:321-326.
25. Hill CS, Treisman R. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
26. Houghton M, Weiner A, Han J, Kuo G, Choo QL. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
27. Hsieh TT, Yao DS, Sheen IS, Liaw YF, Pao CC. 1992. Hepatitis Cvirus in peripheral blood mononuclear cells. Am. J. Clin. Pathol. 98: 392-396.
28. Iwata A, et al. 2011. Extracellular administration of Bcl2 protein reduces apoptosis and improves survival in a murine model of sepsis. PLoS One 6:e14729. doi:10.1371/journal.pone.0014729.
29. Jiang RQ, et al. 2011. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54:900-909.
30. Jones DM, Patel AH, Targett-Adams P, McLauchlan J. 2009. The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J. Virol. 83:2163-2177.
31. Kadoya H, Nagano-Fujii M, Deng L, Nakazono N, Hotta H. 2005. Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol. Immunol. 49:265-273.
32. Kato N, et al. 2000. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32: 405-412.
33. Khokhlatchev AV, et al. 1998. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605-615.
34. Koch JO, Bartenschlager R. 1999. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J. Virol. 73:7138-7146.
35. Kortylewski M, Jove R, Yu H. 2005. Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev. 24:315-327.
36. Kuo G, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
37. Lamelin JP, Zoulim F, Trepo C. 1995. Lymphotropism of hepatitis B and C viruses: an update and a newcomer. Int. J. Clin. Lab. Res. 25:1-6.
38. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
39. kB activation. Virology 391:257-264.
40. Lin Q, et al. 2005. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167:969-980.
41. Liu M, et al. 2007. Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways. FASEB J. 21:1586-1596.
42. Liu S, et al. 2012. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology 56:57-66.
43. Lu LL, et al. 2008. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 371: 61-70.
44. Lundin M, Monne M, Widell A, von Heijne G, Persson MAA. 2003. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 77:5428-5438.
45. Mauro A, et al. 2002. PKCα-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 115:3587-3599.
46. Mellor H, Parker PJ. 1998. The extended protein kinase C superfamily. Biochem. J. 332(Pt 2):281-292.
47. Müller H, et al. 1994. B-lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV). Arch. Virol. Suppl. 9:307-316.
48. Muratori L, et al. 1994. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver 14:124-128.
49. Nunez O, et al. 2004. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53:1665-1672.
50. Paredes AM, Blight KJ. 2008. A genetic interaction between hepatitis C virus NS4B and NS3 is important for RNA replication. J. Virol. 82:10671-10683.
51. Peña LR, Nand S, De Maria N, Van Thiel DH. 2000. REVIEW: Hepatitis C virus infection and lymphoproliferative disorders. Dig. Dis. Sci. 45: 1854-1860.
52. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. 2004. Structural biology of hepatitis C virus. Hepatology 39:5-19.
53. Price MA, Cruzalegui FH, Treisman R. 1996. The p38 and ERK MAPkinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J. 15:6552-6563.
54. Santini G, et al. 1995. HCV and lymphoproliferative diseases. Clin. Exp. Rheumatol. 13(Suppl 13):S51-S57.
55. Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. 2004. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 322:51-60.
56. Schmidt WN, et al. 1998. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells. Hepatology 28:1110-1116.
57. Schmidt WN, et al. 1997. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J. Infect. Dis. 176:20-26.
58. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. 1992. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. U. S. A. 89:5477-5481.
59. Simon AR, et al. 2000. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144-147.
60. Tong WY, et al. 2002. Physical interaction between hepatitis C virus NS4B protein and CREB-RP/ATF6 beta. Biochem. Biophys. Res. Commun. 299:366-372.
61. Turkson J, et al. 1999. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol. Cell. Biol. 19:7519-7528.
62. Wheeler DL, Li Y, Verma AK. 2005. Protein kinase C epsilon signalsultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through induction of specific cytokines in a paracrine mechanism. Photochem. Photobiol. 81:9-18.
63. Yang Y, et al. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). Med. Oncol. 28:796-803.
64. Yu GY, Lee KJ, Gao L, Lai MMC. 2006. Palmitoylation and polymerization of hepatitis C virus NS4B protein. J. Virol. 80:6013-6023.
65. Yu L, Wang L, Chen S. 2012. Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis? Cell. Mol. Life Sci. 69: 935-949.
66. Yu XW, Kennedy RH, Liu SJ. 2003. JAK2/STAT3, not ERK1/2 pathway mediates interleukin-6-elicited inducible NOS activation and decrease in contractility in adult ventricular myocytes. J. Biol. Chem. 278:16304-16309.
67. Zhang Q, et al. 2012. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J. Virol. 86:1544-1554.
68. Zheng Y, et al. 2005. Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response. J. Microbiol. 43:529-536.
69. Zheng Y, et al. 2005. Gene expression profiles of HeLa cells impacted by hepatitis C virus non-structural protein NS4B. J. Biochem. Mol. Biol. 38: 151-160.
70. Zignego AL, et al. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15:382-386.